Fig 1.
Notable historic uses of antibody therapy against infectious diseases.
COVID-19, coronavirus disease 2019; MERS, Middle East respiratory syndrome; SARS, severe acute respiratory syndrome.
Fig 2.
Overview of the use and applications of CP therapy.
Virus-neutralizing antibodies in the plasma of a patient who recovered from COVID-19 can be administered prophylactically to prevent infection in vulnerable individuals and those with known exposure to the virus (Prophylaxis). Convalescent plasma can also be administered to infected individuals to improve the clinical outcome (Treatment). CP, convalescent plasma; COVID-19, coronavirus disease 2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.